The Cardiac Rhythm Management (CRM) Devices And Equipment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for Cardiac Rhythm Management (CRM) devices and equipment has seen significant growth recently. The market will expand from $16.05 billion in 2024 to $17.15 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.8%.
The Cardiac Rhythm Management (CRM) devices and equipment market is projected to reach $21.73 billion in size by 2029, growing at a compound annual growth rate (CAGR) of 6.1%.
Download Your Free Sample of the 2025 Cardiac Rhythm Management (CRM) Devices And Equipment Market Report and Uncover Key Trends Now!The key drivers in the cardiac rhythm management (crm) devices and equipment market are:
• Advancements and innovations in technology
• Integration of telehealth services
• Increased global accessibility to healthcare
• The rise of personalized medicine
The cardiac rhythm management (CRM) devices and equipment market covered in this report is segmented –
1) By Product: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Physicians Clinics
The key trends in the cardiac rhythm management (crm) devices and equipment market are:
• Personalized medicine is becoming a prominent trend in the CRM devices and equipment market.
• Technological innovations, including the development of leadless CRM devices and biodegradable devices, are shaping the industry's future.
• Telehealth integration is another emerging trend in the market.
• The adoption of combination therapies is increasingly gaining traction in the CRM devices and equipment market.
Major companies in the cardiac rhythm management (crm) devices and equipment market are:
• Abbott Laboratories
• Medtronic plc
• Biotronik SE & Co KG
• Cardiac Science Corporation
• Schiller AG
• Hill-Rom Holdings Inc.
• GE Healthcare
• Integer Holdings
• Neovasc Inc.
• Philips Healthcare
• Stryker Corporation
• Rochling Medical
• CCC Medical Devices
• LivaNova plc
• ZOLL Medical Corporation
• Koninklijke Philips N.V
• Applied Cardiac System
• Cook Medical
• Abiomed Inc.
• Berlin Heart GmbH
• Brotionik SE and Co. KG
• Jarvik Hearth Inc.
• MicroPort Scientific Corp
• ReliantHeart Inc.
• Shree Pacetronix Ltd.
• Shaanxi Qinming Medical Instrument Co. Ltd.
• AtriCure Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• ProgettiSrl
North America was the largest region in the global cardiac rhythm management (CRM) devices and equipment market in 2023